Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER × talazoparib × Clear all

Phase

Status

Recruiting 22 Completed 16 Active not recruiting 9 Withdrawn 5 Terminated 5 Unknown 4 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration Resistant Prostate Cancer (mCRPC) 1

Interventions

Specimen Handling 15 Magnetic Resonance Spectroscopy 14 Cyclophosphamide 10 Cisplatin 7 Biopsy 7 Bevacizumab 7 pembrolizumab 6 Nivolumab 6 Radiosurgery 5 Doxorubicin 5 Capecitabine 5 fludarabine 4 atezolizumab 4 Vincristine 4 S 1 (combination) 4 Prednisone 4 Oxaliplatin 4 Irinotecan 4 Gemcitabine 4 Fluorouracil 4 Etoposide 4 Drug Therapy 4 Cytarabine 4 Carboplatin 4 durvalumab 3 Surveys and Questionnaires 3 Rituximab 3 Radiation 3 Melphalan 3 Leucovorin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05425862 2023-12-11

REPAIR

Peter MacCallum Cancer Centre, Australia

Phase 1 Suspended

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡